80 related articles for article (PubMed ID: 28734272)
21. Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease.
Taniguchi M; Okayama Y; Hashimoto Y; Kitaura M; Jimbo D; Wakutani Y; Wada-Isoe K; Nakashima K; Akatsu H; Furukawa K; Arai H; Urakami K
Dement Geriatr Cogn Disord; 2008; 26(2):117-22. PubMed ID: 18654083
[TBL] [Abstract][Full Text] [Related]
22. Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer's disease brain, serum and cerebrospinal fluid towards potential biomarker discovery.
Gizaw ST; Ohashi T; Tanaka M; Hinou H; Nishimura S
Biochim Biophys Acta; 2016 Aug; 1860(8):1716-27. PubMed ID: 26968461
[TBL] [Abstract][Full Text] [Related]
23. Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease.
Hülsmeier AJ; Tobler M; Burda P; Hennet T
Sci Rep; 2016 Oct; 6():33927. PubMed ID: 27725718
[TBL] [Abstract][Full Text] [Related]
24. [Study on the determination of IgA, IgG, IgM, a1-antitrypsin, haptoglobin and transferrin with the kinetic nephelometric method. Comparison with the radial immunodiffusion method (author's transl)].
Liappis N
Klin Padiatr; 1980 Jul; 192(4):370-8. PubMed ID: 6779053
[TBL] [Abstract][Full Text] [Related]
25. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
26. Multiple Reaction Monitoring for the Quantitation of Serum Protein Glycosylation Profiles: Application to Ovarian Cancer.
Miyamoto S; Stroble CD; Taylor S; Hong Q; Lebrilla CB; Leiserowitz GS; Kim K; Ruhaak LR
J Proteome Res; 2018 Jan; 17(1):222-233. PubMed ID: 29207246
[TBL] [Abstract][Full Text] [Related]
27. Acute phase reactant proteins in differential diagnosis of monoclonal gammopathy.
San Miguel J; Corrales A; Alberca I; Vicente V; Lopez Borrasca A
Neoplasma; 1983; 30(1):57-62. PubMed ID: 6403877
[TBL] [Abstract][Full Text] [Related]
28. Quantitative determination of haptoglobin glycoform variants in psoriasis.
Maresca B; Cigliano L; Corsaro MM; Pieretti G; Natale M; Bucci EM; Dal Piaz F; Balato N; Nino M; Ayala F; Abrescia P
Biol Chem; 2010 Dec; 391(12):1429-39. PubMed ID: 21087091
[TBL] [Abstract][Full Text] [Related]
29. [Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer].
Kovcić V; Jelić S; Filipović I; Tomasević Z
Srp Arh Celok Lek; 1994; 122(11-12):311-3. PubMed ID: 17974404
[TBL] [Abstract][Full Text] [Related]
30. Differential susceptibility of transferrin glycoforms to chymotrypsin: a proteomics approach to the detection of carbohydrate-deficient transferrin.
Valmu L; Kalkkinen N; Husa A; Rye PD
Biochemistry; 2005 Dec; 44(49):16007-13. PubMed ID: 16331960
[TBL] [Abstract][Full Text] [Related]
31. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
32. Characterization of transferrin glycoforms in human serum by CE-UV and CE-ESI-MS.
Sanz-Nebot V; Balaguer E; Benavente F; Neusüss C; Barbosa J
Electrophoresis; 2007 Jun; 28(12):1949-57. PubMed ID: 17523137
[TBL] [Abstract][Full Text] [Related]
33. Glycosylation of alpha-1-proteinase inhibitor and haptoglobin in ovarian cancer: evidence for two different mechanisms.
Turner GA; Goodarzi MT; Thompson S
Glycoconj J; 1995 Jun; 12(3):211-8. PubMed ID: 7496134
[TBL] [Abstract][Full Text] [Related]
34. Transferrin microheterogeneity in human perilymph.
Rauch SD
Laryngoscope; 2000 Apr; 110(4):545-52. PubMed ID: 10763998
[TBL] [Abstract][Full Text] [Related]
35. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
36. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
[TBL] [Abstract][Full Text] [Related]
37. Antipsychotic treatment of acute paranoid schizophrenia patients with olanzapine results in altered glycosylation of serum glycoproteins.
Telford JE; Bones J; McManus C; Saldova R; Manning G; Doherty M; Leweke FM; Rothermundt M; Guest PC; Rahmoune H; Bahn S; Rudd PM
J Proteome Res; 2012 Jul; 11(7):3743-52. PubMed ID: 22594947
[TBL] [Abstract][Full Text] [Related]
38. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
39. High-performance liquid chromatography coupled to mass spectrometry methodology for analyzing site-specific N-glycosylation patterns.
Ozohanics O; Turiák L; Puerta A; Vékey K; Drahos L
J Chromatogr A; 2012 Oct; 1259():200-12. PubMed ID: 22677411
[TBL] [Abstract][Full Text] [Related]
40. LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins.
Halim A; Rüetschi U; Larson G; Nilsson J
J Proteome Res; 2013 Feb; 12(2):573-84. PubMed ID: 23234360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
